Cerebral Artery Syndrome Treatment Market Trends

  • Report ID: 3463
  • Published Date: Nov 19, 2025
  • Report Format: PDF, PPT

Cerebral Artery Syndrome Treatment Market - Growth Drivers and Challenges

Growth Drivers

  • Growing Research and Development Activities - The advancement of cerebral artery syndrome treatment is greatly aided by research and development efforts. Researchers are always looking into new ways to treat cerebral artery syndromes, like targeted drug delivery systems, gene therapy, and stem cell therapy. These approaches have the potential to completely change the way that the condition is treated. Research has a crucial role in determining how the market for cerebral artery syndrome treatments will develop in the future by promoting improvements in care and therapy. For instance, using a novel approach to preclinical animal testing, researchers have identified uric acid as a potential therapy to enhance recovery from acute ischemic stroke using a new method for conducting preclinical animal research. In the study, researchers from the National Institutes of Health’s Stroke Preclinical Assessment Network (SPAN) rigorously tested the effectiveness of six novel therapies in reducing ischemic brain injury in rodents using strategies normally reserved for clinical studies in humans.
  • Growing Technological Advancements in Healthcare Industry - Advances in imaging technology, including computed tomography (CT), magnetic resonance imaging (MRI), and other imaging modalities, have made cerebral artery syndrome diagnosis and therapy more accurate. As per a report, approximately 5.8,000 magnetic resonance imaging (MRI) machines were in operation globally in 2021. Also, it has been predicted that by 2030, there will be more than 10,000 MRI units worldwide. These medical imaging technologies enable physicians to precisely and thoroughly visualize the brain and blood arteries, assisting them in determining the precise location, scope, and severity of the ailment. Treatment plans might be more focused and successful when an accurate diagnosis is made. Considering all this, the cerebral artery syndrome treatment market is anticipated to grow significantly in the upcoming years.  
  • Growing Awareness among the Individuals regarding the Cerebral Artery Syndrome - Increasing awareness about cerebral artery syndrome and improved diagnostics techniques have also contributed to market growth. Also, public health campaigns are playing a major role in spreading awareness about the signs and symptoms of strokes. Further, social media platforms are helping to educate individuals about strokes and their prevention in the early stages. Therefore, these factors are propelling the growth of the market.

Challenges

  • High Cost Associated with the Treatment - Advanced therapies and procedures, such as neurointerventional techniques can be expensive, limiting access to these treatments for some patients. Affordability and accessibility are important factors in ensuring that all individuals with cerebral artery syndrome have access to appropriate care. Also, the cost of the treatment can go from USD 27,473 to USD 70,601, which is quite expensive for most patients. Therefore, the high cost may hinder the expansion of the cerebral artery syndrome treatment market.
  • Limited Accessibility to Reversal Agents for Anticoagulants may hamper the Growth of the Market.
  • Severe Side Effects of some Drugs and Treatments may Hinder the Growth of the Market.

Base Year

2025

Forecast Year

2026-2035

CAGR

6.3%

Base Year Market Size (2025)

USD 2.24 billion

Forecast Year Market Size (2035)

USD 4.13 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of cerebral artery syndrome treatment is estimated at USD 2.37 billion.

The global cerebral artery syndrome treatment market size crossed USD 2.24 billion in 2025 and is likely to register a CAGR of over 6.3%, exceeding USD 4.13 billion revenue by 2035.

North America is set to account for the largest revenue share of 35% by 2035, driven by rising awareness of minimally invasive stroke treatments and increasing prevalence of atrial fibrillation.

Key players in the market include Bristol Myers Squibb, Athersys, Inc., Janssen Pharmaceuticals, Inc, Royal Philips, AstraZeneca plc, Daiichi Sankyo Company, Limited, LIFESCAPES Inc, Shionogi & Co., Ltd., Fujitsu, Takeda Pharmaceutical Co Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos